Related references
Note: Only part of the references are listed.Biopolymer Immune Implants' Sequential Activation of Innate and Adaptive Immunity for Colorectal Cancer Postoperative Immunotherapy
Guofeng Ji et al.
ADVANCED MATERIALS (2021)
Supramolecular Assembled Programmable Nanomedicine As In Situ Cancer Vaccine for Cancer Immunotherapy
Yu Zhang et al.
ADVANCED MATERIALS (2021)
Multifunctional Dendronized Polypeptides for Controlled Adjuvanticity
Zhiyuan Fan et al.
BIOMACROMOLECULES (2021)
Prolonged activation of innate immune pathways by a polyvalent STING agonist
Suxin Li et al.
NATURE BIOMEDICAL ENGINEERING (2021)
A simple and general strategy for postsurgical personalized cancer vaccine therapy based on an injectable dynamic covalent hydrogel
Zhentao Yu et al.
BIOMATERIALS SCIENCE (2021)
Smart materials for drug delivery and cancer therapy
Yao Yang et al.
VIEW (2021)
Dual fluorescence imaging-guided programmed delivery of doxorubicin and CpG nanoparticles to modulate tumor microenvironment for effective chemo-immunotherapy
Xia Dong et al.
BIOMATERIALS (2020)
Molecular mechanisms and cellular functions of cGAS-STING signalling
Karl-Peter Hopfner et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Controlling timing and location in vaccines
Darrell J. Irvine et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy
Jun Xu et al.
NATURE NANOTECHNOLOGY (2020)
Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic
Emily N. Chin et al.
SCIENCE (2020)
Nanotherapeutics for Immuno-Oncology: A Crossroad for New Paradigms
Wantong Song et al.
TRENDS IN CANCER (2020)
Nanoparticle systems for cancer vaccine
Ru Wen et al.
NANOMEDICINE (2019)
Structural basis of STING binding with and phosphorylation by TBK1
Conggang Zhang et al.
NATURE (2019)
Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
Lei Miao et al.
NATURE BIOTECHNOLOGY (2019)
The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8+ T Cell Responses
Cheol Gyun Kim et al.
PHARMACEUTICS (2019)
Schaftoside ameliorates oxygen glucose deprivation-induced inflammation associated with the TLR4/Myd88/Drp1-related mitochondrial fission in BV2 microglia cells
Kecheng Zhou et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2019)
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
Daniel Shae et al.
NATURE NANOTECHNOLOGY (2019)
Leveraging biomaterials for cancer immunotherapy: targeting pattern recognition receptors
W. Song et al.
MATERIALS TODAY NANO (2019)
A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
Tingting Wang et al.
NATURE COMMUNICATIONS (2018)
Immunomodulation of the NLRP3 Inflammasome through Structure-Based Activator Design and Functional Regulation via Lysosomal Rupture
Saikat Manna et al.
ACS CENTRAL SCIENCE (2018)
Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
Rui Kuai et al.
SCIENCE ADVANCES (2018)
Design of amidobenzimidazole STING receptor agonists with systemic activity
Joshi M. Ramanjulu et al.
NATURE (2018)
BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma
Qi Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai et al.
NATURE MATERIALS (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
A STING-activating nanovaccine for cancer immunotherapy
Min Luo et al.
NATURE NANOTECHNOLOGY (2017)
Nanomaterials for cancer immunotherapy
Wantong Song et al.
BIOMATERIALS (2017)
Liposomal Delivery Enhances Immune Activation by STING Agonists for Cancer Immunotherapy
Sandeep T. Koshy et al.
ADVANCED BIOSYSTEMS (2017)
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
Alena Gros et al.
NATURE MEDICINE (2016)
Activation of STING requires palmitoylation at the Golgi
Kojiro Mukai et al.
NATURE COMMUNICATIONS (2016)
Vaccines for established cancer: overcoming the challenges posed by immune evasion
Sjoerd H. van der Burg et al.
NATURE REVIEWS CANCER (2016)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
Cyclic GMP-AMP Containing Mixed Phosphodiester Linkages Is An Endogenous High-Affinity Ligand for STING
Xu Zhang et al.
MOLECULAR CELL (2013)
STING Specifies IRF3 Phosphorylation by TBK1 in the Cytosolic DNA Signaling Pathway
Yasuo Tanaka et al.
SCIENCE SIGNALING (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Martin F. Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Sai T. Reddy et al.
NATURE BIOTECHNOLOGY (2007)
Share Paper
